Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Bone Marrow Transplantation
|
April 7, 2005
Novel approaches in GVHD therapy
J Svennilson
Pediatric Transplantation
|
November 18, 2000
Is it time to reduce toxicity by non-myeloablative conditioning for allogeneic stem cell transplantation in children?
J Svennilson, O Ringdén
The International Journal of Developmental Biology
|
October 27, 1999
Dopamine in the developing kidney
J Svennilson, A Aperia
Pediatric Nephrology (Berlin, Germany)
|
December 22, 1999
Age-dependent expression of protein phosphatase 2A in the developing rat kidney
J Svennilson, A Sandberg-Nordqvist, A Aperia
Kidney International
|
November 5, 1997
Protein kinase C in the developing kidney: isoform expression and effects of ceramide and PKC inhibitors
E Serlachius, J Svennilson, M Schalling, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)
|
August 2, 2001
Increased blood pressure and loss of anp-induced natriuresis in mice lacking DARPP-32 gene
A C Eklöf, U Holtbäck, J Svennilson, et al.
Bone Marrow Transplantation
|
July 29, 2008
A reduced intensity conditioning protocol associated with excellent survival in patients with myelofibrosis
B George, I Kerridge, D Gottlieb, et al.
Bone Marrow Transplantation
|
November 20, 2002
The graft-versus-leukaemia effect in haematopoietic stem cell transplantation using unrelated donors
M Remberger, J Mattsson, P Hentschke, et al.
Internal Medicine Journal
|
February 18, 2009
Single versus double unrelated umbilical cord blood units for allogeneic transplantation in adults with advanced haematological malignancies: a retrospective comparison of outcomes
K Bradstock, M Hertzberg, I Kerridge, et al.
Kidney International
|
July 1, 1995
Evidence for a role of protein phosphatases 1 and 2A during early nephrogenesis
J Svennilson, M Durbeej, G Celsi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Bone Marrow Transplantation
|
April 7, 2005
Novel approaches in GVHD therapy
J Svennilson
Pediatric Transplantation
|
November 18, 2000
Is it time to reduce toxicity by non-myeloablative conditioning for allogeneic stem cell transplantation in children?
J Svennilson, O Ringdén
The International Journal of Developmental Biology
|
October 27, 1999
Dopamine in the developing kidney
J Svennilson, A Aperia
Pediatric Nephrology (Berlin, Germany)
|
December 22, 1999
Age-dependent expression of protein phosphatase 2A in the developing rat kidney
J Svennilson, A Sandberg-Nordqvist, A Aperia
Kidney International
|
November 5, 1997
Protein kinase C in the developing kidney: isoform expression and effects of ceramide and PKC inhibitors
E Serlachius, J Svennilson, M Schalling, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)
|
August 2, 2001
Increased blood pressure and loss of anp-induced natriuresis in mice lacking DARPP-32 gene
A C Eklöf, U Holtbäck, J Svennilson, et al.
Bone Marrow Transplantation
|
July 29, 2008
A reduced intensity conditioning protocol associated with excellent survival in patients with myelofibrosis
B George, I Kerridge, D Gottlieb, et al.
Bone Marrow Transplantation
|
November 20, 2002
The graft-versus-leukaemia effect in haematopoietic stem cell transplantation using unrelated donors
M Remberger, J Mattsson, P Hentschke, et al.
Internal Medicine Journal
|
February 18, 2009
Single versus double unrelated umbilical cord blood units for allogeneic transplantation in adults with advanced haematological malignancies: a retrospective comparison of outcomes
K Bradstock, M Hertzberg, I Kerridge, et al.
Kidney International
|
July 1, 1995
Evidence for a role of protein phosphatases 1 and 2A during early nephrogenesis
J Svennilson, M Durbeej, G Celsi, et al.
Page
of 2